Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.
